Clinical Trial Update: Maintenance Immune Check-point Inhibitor Following Post-operative Chemo-radiation in Subjects With HPV-negative HNSCC [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating maintenance immune checkpoint inhibitor after post-operative chemoradiation in HPV-negative head and neck squamous cell carcinoma has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Squamous Cell Head and Neck Carcinoma | Phase 3 | Status: WITHDRAWN